BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 18.03.1999

Animal Drugs, Feeds, and Related Products; Lincomycin

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of three supplemental new animal drug applications (NADA's) filed by Pharmacia & Upjohn Co. The supplemental NADA's provide new tolerances and withdrawal times for use of lincomycin, and codification of an acceptable daily intake (ADI).

Source: Federal Register — Food and Drug AdministrationOpen original release →